Excelya is delighted to share a significant achievement that reinforces our ongoing dedication to security, quality and trust. We have successfully received our ISO 27001 recertification, valid until October 2028, following a detailed external audit carried out by Swiss Approval International on October 16th, 2025.
This recertification was granted with zero findings, a remarkable outcome that highlights the strength of our Information Security Management System and the daily commitment of our teams across the organization. Protecting the data of our clients and partners is a responsibility we embrace with rigor and pride, and this result reflects the maturity and reliability of our approach.
The project was driven by our Global Quality Assurance Department, working closely with our IT Department and all contributors involved throughout the process. Their work demonstrates how our values of Audacity, Care and Energy influence everything we do and how they guide us toward the highest standards in our industry.
This new milestone not only reinforces Excelya’s position as a trusted partner in clinical research but also underlines our continued focus on operational excellence, regulatory compliance and continuous improvement. As we move forward, we remain fully committed to safeguarding information, strengthening our systems and delivering the dependable support our clients expect.
To learn more about our services or to discuss how we can support your projects, please submit your request.
Excelya is committed to helping our clients deliver life-changing therapies collaboratively, so we can transform tomorrow together.
Our global network of experts across 28 countries understand your critical needs to provide bespoke and robust trial solutions across a broad spectrum of therapeutic areas with care.
We support Biotech, Pharma, and Medical Device organizations to make healthcare advancements. Our unique business model enables us to provide quality, flexible, and expert full-service CRO, FSP, and Resourcing solutions.
